The Chinese State Department has awarded nine preferential policies to Lecheng International Medical Tourism Pilot Zone: 1. fast approval and registration for medical devices and drugs; 2. permission for stem cell research and development; 3. permission for equipment import of medical institutions; 4. permission to practice up to 3 years for foreign medical practitioners; 5. permission for foreign investors to invest in medical institutions in the Pilot Zone; 6. reduction of import duties for medical equipment into the Zone; 7. Allocating more land for developmental uses of the Zone; 8. Attracting international organizations into the zone; 9. encouraging multi-channel financing from the general public.
Nine Golden Policies
Specially-Permitted Drug and Medical Device Free Trade
Specially-Permitted Drug and Medical Device Tracking Platform
As the only unregistered specially-permitted drug and medical divice tracking platform in China, it only takes three days to approve drugs and medical devices that are approved in other countries but are not registered in China so that innovative drugs and medical device can be launched simultaneously in both international and domestic markets.
Bonded Warehouse for Specially-Permitted Drug and Medical Device Storage
Haikou Customs allows drugs and medical devices to be stored at the bonded warehouse before the quarantine process to improve import efficiency and encourage bulk import. The bonded warehouse will provice services such as customs clearing, warehousing, transportation, and delivery services to lower costs.
The only Permanent Innovative Drug and Medical Device Expo in China, it is an online and offline exhibition and training platform. Through this all-new window of international innovative drug and medical device, both doctors and patients can enjoy the benefits of innovative drugs and medical devices in synchronization with the rest of the world.
The need for special registration (NMPA) in China for approved or registered foreign medical device and pharmacuetical is the main factor that inhibits international companies from entering the Chinese market.
The central government of China has recently implemented regulatory changes for a special designated pilot zone, namely, Hainan Boao Lecheng Medical Tourism Pilot Zone, to provide medical treatment and import medical device and drug that have been approved by FDA and/or CE. These new policies enable fast introduction of innovationive and new treatments to Chinese patients.
International medical companies can leverage the new polices for the establishment of commercial sites in China and expedite the China NMPA registration process based on the Real-World Data path, reducing both time and cost significantly.
With more than twenty years of experience in both the US and China, Zenyth Technologies is an ideal partner in your venture into the China market. We fund, accelarate, and market both products and companies.